Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy

[1] Aguiar PN(2016)The role of PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: a network meta-analysis Immunotherapy 8 479-488

[2] Santoro IL(2017)PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation Int J Cancer 141 1402-1412

[3] Tadokoro H(2015)Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: significance in claudin-low breast cancer cells Mol Cancer 14 149-3643

[4] de Lima LG(2008)B7–H1 is a ubiquitous antiapoptotic receptor on cancer cells Blood 111 3635-10567

[5] Filardi BA(2016)Activation of the PD-1/PD-L1 immune checkpoint confers tumor cell chemoresistance associated with increased metastasis Oncotarget 7 10557-1241

[6] Oliveira P(2015)Metabolic competition in the tumor microenvironment is a driver of cancer progression Cell 162 1229-6023

[7] Almozyan S(2014)B7–H1 expression associates with tumor invasion and predicts patient's survival in human esophageal cancer Int J Clin Exp Pathol 7 6015-416

[8] Colak D(2016)Regulation of PD-L1: a novel role of pro-survival signalling in cancer Ann Oncol 27 409-7924

[9] Mansour F(2016)The role of PD-L1 in the radiation response and prognosis for esophageal squamous cell carcinoma related to IL-6 and T-cell immunosuppression Oncotarget 7 7913-988

[10] Alaiya A(2017)Tumor cell-intrinsic CD274/PD-L1: a novel metabolic balancing act with clinical potential Autophagy 13 987-1846

[1] Aguiar PN(2016)The role of PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: a network meta-analysis Immunotherapy 8 479-488

[2] Santoro IL(2017)PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation Int J Cancer 141 1402-1412

[3] Tadokoro H(2015)Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: significance in claudin-low breast cancer cells Mol Cancer 14 149-3643

[4] de Lima LG(2008)B7–H1 is a ubiquitous antiapoptotic receptor on cancer cells Blood 111 3635-10567

[5] Filardi BA(2016)Activation of the PD-1/PD-L1 immune checkpoint confers tumor cell chemoresistance associated with increased metastasis Oncotarget 7 10557-1241

[6] Oliveira P(2015)Metabolic competition in the tumor microenvironment is a driver of cancer progression Cell 162 1229-6023

[7] Almozyan S(2014)B7–H1 expression associates with tumor invasion and predicts patient's survival in human esophageal cancer Int J Clin Exp Pathol 7 6015-416

[8] Colak D(2016)Regulation of PD-L1: a novel role of pro-survival signalling in cancer Ann Oncol 27 409-7924

[9] Mansour F(2016)The role of PD-L1 in the radiation response and prognosis for esophageal squamous cell carcinoma related to IL-6 and T-cell immunosuppression Oncotarget 7 7913-988

[10] Alaiya A(2017)Tumor cell-intrinsic CD274/PD-L1: a novel metabolic balancing act with clinical potential Autophagy 13 987-1846